Statistics
Publications
58
Citations
5K
H-Index
36
Active since
1973
Michael W. Dunne is an author at Pfizer (United States) specializing in medicine, drug resistance, and antibiotics.
Publications per year
1973–2025
58
58
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 735 citations · Full text
Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
Helen W. Boucher, Mark Wilcox, George H. Talbot et al. · New England Journal of Medicine · 2014 · 420 citations · Full text
Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 359 citations
Azithromycin for the Secondary Prevention of Coronary Heart Disease Events
Christopher M. O’Connor, Michael W. Dunne, Marc A. Pfeffer et al. · JAMA · 2003 · 325 citations
1–5 of 58